Vancheri, Carlo
Overview
Works: | 6 works in 7 publications in 1 language and 13 library holdings |
---|---|
Roles: | Author, Contributor |
Publication Timeline
.
Most widely held works by
Carlo Vancheri
Pirfenidone in Idiopathic Pulmonary Fibrosis: Expert Panel Discussion on the Management of Drug-Related Adverse Events by
Ulrich Costabel(
)
2 editions published in 2014 in English and held by 3 WorldCat member libraries worldwide
Pirfenidone is currently the only approved therapy for idiopathic pulmonary fibrosis, following studies demonstrating that treatment reduces the decline in lung function and improves progression-free survival. Although generally well tolerated, a minority of patients discontinue therapy due to gastrointestinal and skin-related adverse events (AEs). This review summarizes recommendations based on existing guidelines, research evidence, and consensus opinions of expert authors, with the aim of providing practicing physicians with the specific clinical information needed to educate the patient and better manage pirfenidone-related AEs with continued pirfenidone treatment. The main recommendations to help prevent and/or mitigate gastrointestinal and skin-related AEs include taking pirfenidone during (or after) a meal, avoiding sun exposure, wearing protective clothing, and applying a broad-spectrum sunscreen with high ultraviolet (UV) A and UVB protection. These measures can help optimize AE management, which is key to maintaining patients on an optimal treatment dose
2 editions published in 2014 in English and held by 3 WorldCat member libraries worldwide
Pirfenidone is currently the only approved therapy for idiopathic pulmonary fibrosis, following studies demonstrating that treatment reduces the decline in lung function and improves progression-free survival. Although generally well tolerated, a minority of patients discontinue therapy due to gastrointestinal and skin-related adverse events (AEs). This review summarizes recommendations based on existing guidelines, research evidence, and consensus opinions of expert authors, with the aim of providing practicing physicians with the specific clinical information needed to educate the patient and better manage pirfenidone-related AEs with continued pirfenidone treatment. The main recommendations to help prevent and/or mitigate gastrointestinal and skin-related AEs include taking pirfenidone during (or after) a meal, avoiding sun exposure, wearing protective clothing, and applying a broad-spectrum sunscreen with high ultraviolet (UV) A and UVB protection. These measures can help optimize AE management, which is key to maintaining patients on an optimal treatment dose
Erratum to: Pirfenidone in Idiopathic Pulmonary Fibrosis: Expert Panel Discussion on the Management of Drug-Related Adverse
Events by
Ulrich Costabel(
)
1 edition published in 2014 in English and held by 2 WorldCat member libraries worldwide
1 edition published in 2014 in English and held by 2 WorldCat member libraries worldwide
Clinical and radiological features of idiopathic interstitial pneumonias (IIPs): a pictorial review by Stefano Palmucci(
)
1 edition published in 2014 in English and held by 2 WorldCat member libraries worldwide
1 edition published in 2014 in English and held by 2 WorldCat member libraries worldwide
Design of a Study Assessing Disease Behaviour During the Peri-Diagnostic Period in Patients with Interstitial Lung Disease:
The STARLINER Study by
Marlies Wijsenbeek(
)
1 edition published in 2018 in English and held by 2 WorldCat member libraries worldwide
1 edition published in 2018 in English and held by 2 WorldCat member libraries worldwide
Idiopathic pulmonary fibrosis and cancer: do they really look similar? by
Carlo Vancheri(
)
1 edition published in 2015 in English and held by 2 WorldCat member libraries worldwide
1 edition published in 2015 in English and held by 2 WorldCat member libraries worldwide
Interaction between human lung fibroblasts and T-lymphocytes prevents activation of CD4+cells by
Carlo Vancheri(
)
1 edition published in 2005 in English and held by 2 WorldCat member libraries worldwide
1 edition published in 2005 in English and held by 2 WorldCat member libraries worldwide
Audience Level
0 |
![]() |
1 | ||
General | Special |
